Cynata Therapeutics Limited
CYYNF
$0.118
$0.01615.69%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 35.98% | 34.39% | 33.57% | 4.98% | -38.71% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -1.93% | -1.45% | -2.33% | 30.35% | 98.40% |
| Total Other Non-Cash Items | -43.78% | -44.57% | -45.28% | 252.07% | 208.96% |
| Change in Net Operating Assets | -3.46% | -3.46% | -3.46% | -471.25% | -163.84% |
| Cash from Operations | 33.01% | 32.04% | 32.06% | 13.77% | -12.58% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 13.62% | -43.19% | -- | 0.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -60.67% | 19.67% | -- | 0.00% | -- |
| Cash from Financing | 8.94% | -44.77% | -- | -2.27% | -- |
| Foreign Exchange rate Adjustments | 36.80% | 60.41% | 99.38% | 46.04% | 15.75% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 87.67% | 18.36% | -27.60% | 18.45% | 51.70% |